Therapeutic Response of Cannabidiol in Rheumatoid Arthritis
Status:
Recruiting
Trial end date:
2025-06-10
Target enrollment:
Participant gender:
Summary
The study will randomly assign Rheumatoid Arthritis (RA) patients on stable RA therapy to
either placebo or cannabidiol (CBD). The overall goal of this proposal is to examine the
efficacy and safety of CBD treatment as adjunctive to the medical management of RA patients.